Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Macular degeneration Stories

2013-10-17 08:30:27

Novartis's Lucentis Remains the Most Preferred Intravitreal Pharmacotherapy for Wet AMD Across the EU5, According to a New Report from BioTrends Research Group EXTON, Pa., Oct. 17, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that, eight months after the approval of Bayer's Eylea for the treatment of wet age-related macular degeneration (AMD), nearly half of surveyed retinal...

2013-10-10 10:27:13

New study reports successful use in mice; implications for both forms of AMD Researchers from Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences have identified a possible topical treatment for age-related macular degeneration (AMD) in a study of mice that shows promise for clinical use. The research findings, published today in PLOS ONE, are the first to report successful topical use of a compound capable of inhibiting symptoms associated with both...

2013-10-09 23:01:53

US optometrist group IALVS joins WHO and other international agencies on World Sight Day October 10, 2013 to focus attention on vision impairment and blindness. Corona, California (PRWEB) October 09, 2013 Universal Eye Health is the theme for World Sight Day 2013 and this year’s call to action is simple: get your eyes tested. It’s a mantra that has long been adopted by the International Academy of Low Vision Specialists (IALVS), a group of United States optometrists who provide...

2013-10-09 12:08:08

A team of researchers at Georgetown University Medical Center (GUMC) has found that loss of an anti-aging gene induces retinal degeneration in mice and might contribute to age-related macular degeneration, the major cause of blindness in the elderly. In the Oct. 9 issue of the Journal of Neuroscience, the scientists demonstrated a key role for the aging-suppressor gene Klotho in maintaining the health of the mouse and human retina. They say that in their animal studies, loss of Klotho...

2013-10-08 23:32:40

Public forum on living with macular degeneration will be held in Wilton, Connecticut. Wilton, Connecticut (PRWEB) October 08, 2013 A panel of experts is slated to discuss macular degeneration, the leading cause of irreversible vision loss and low vision in older adults. The free informational seminar entitled “Finding Hope when Vision Fails” will be held on Saturday, November 2, 2013 at The Greens at Cannondale in Wilton, Connecticut. Dr. David Tom, from New England Retina...

2013-10-01 12:31:06

LEUVEN, Belgium, October 1, 2013 /PRNewswire/ -- Largest ever retrospective review of VMA/VMT patients confirms early treatment initiation may stop disease progression and lead to better visual function outcome - Retrospective review of patients presenting with vitreomacular adhesion (VMA), vitreomacular traction (VMT), macular hole (MH) with/ without VMA, with or without visual...

2013-09-30 23:18:02

National Optometrist Group Offers Macular Degeneration Sufferers Solutions Which Allow Patients to Drive Cars and Pursue Normal Activities Again Corona, CA (PRWEB) September 30, 2013 While a diagnosis of Age Related Macular Degeneration (AMD) can be devastating, it does not mean that all patients will be relegated to a life spent unable to travel far from home. Members of the International Academy of Low Vision Specialists suggest patients get a second opinion, because there are things...

2013-09-27 08:26:07

HAMBURG, Germany, Sept. 27, 2013 /PRNewswire/ -- The Angiogenesis Foundation released a white paper at the 13(th) Euretina Congress that addresses the barriers faced by individuals worldwide in obtaining optimal care for wet age-related macular degeneration (wet AMD). Wet AMD is the most common form of blindness in people 50 years or older in developed nations. The white paper, "Advocating for the Improved Treatment and Outcomes for Wet Age-Related Macular Degeneration," is the result...

2013-09-26 23:32:49

On Saturday, November 9, 2013, the south Florida community will have the opportunity to walk at Hugh Taylor Birch State Park in Fort Lauderdale, in support of finding a cure for blinding retinal diseases. Fort Lauderdale, Florida (PRWEB) September 26, 2013 On Saturday, November 9, 2013, the south Florida community will have the opportunity to walk at Hugh Taylor Birch State Park in Fort Lauderdale, in support of finding a cure for blinding retinal diseases. According to the Foundation...

2013-09-25 08:29:22

Humanized Antibody for Orphan & Non-Orphan Ocular Disorders CLEVELAND, Sept. 25, 2013 /PRNewswire-USNewswire/ -- Today NovelMed Therapeutics announced preclinical study results for its lead compound in two models of AMD, a major cause of blindness affecting more than 2 million people in the United States. (Logo: http://photos.prnewswire.com/prnh/20130909/DC73243LOGO) Two independent preclinical investigations demonstrated that NovelMed's lead compound, an alternative pathway...